Rituximab for Prevention of Rejection After Renal Transplantation

NCT00565331 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Rituximab
DRUG: Placebo

Sponsor

Radboud University Medical Center

Collaborators

[object Object]
[object Object]